MAM
TARO

Mizuho Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Mizuho Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$13K Hold
118
– – ﹤0.01% 664
2016
Q2 		$17K Buy
+118
New +$16.7K ﹤0.01% 673
2016
Q1 		– Sell
-118
Closed -$18K – 711
2015
Q4 		$18K Buy
+118
New +$17.2K ﹤0.01% 684

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mizuho Asset Management's TARO Position: Q3 2016 in Review

Mizuho Asset Management held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q3 2016 at 118 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Mizuho Asset Management first reported a position in TARO in Q4 2015 and has held it in 3 quarters since. The position peaked at $18K in Q4 2015. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

  • Mizuho Asset Management held 118 shares of Taro Pharmaceutical Industries Ltd. worth $13K as of Q3 2016.
  • Mizuho Asset Management left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q3 2016.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Mizuho Asset Management's portfolio in Q3 2016, its #664 holding.
  • Mizuho Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and has held it in 3 quarters since.
  • Mizuho Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $18K in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.